— the life science, pharmaceutical and healthcare portal

04:44 EST 28th December 2014 — BioPortfolio

Breaking News at 04:44 EST 28th December 2014

Latest BioPortfolio blog: Medtronic in $43bn acquisition of Covidien - comment from Healthcare Analyst at The Economist Intelligence Unit

"Given the hostile reaction on both sides of the Atlantic to Pfizer's proposed tax inversion deal with AstraZeneca, it is no wonder that Medtronic is playing down the tax benefits of its deal with Covidien. Instead it is predicting innovation be... — Read more

Search BioPortfolio: